The Chiesi FAST Discovery Award recognizes the aspiring life-science companies and entrepreneurs who are driving scientific innovation to cure rare disease and developing novel tools and platform technologies for applications in nucleotide therapeutics.

Chiesi is interested in applications from interested startups developing innovative approaches in the following discovery and early clinical areas of interest:

• In vivo gene editing
• In vivo gene therapy approaches
• Nucleotide delivery technologies

Chiesi’s target therapeutic areas within rare diseases are:

• Hematology
• Immunology
• Dermatology
• Ophthalmology
• Endo-metabolic
• Inborn errors of metabolism

Your non-confidential application should highlight your innovative approach to advancing therapies for patients with high unmet needs. All submissions will be reviewed by Chiesi, and one awardee will be selected to receive the Chiesi FAST Discovery Award, a fast-tracked spot in the Fall 2024 FAST California program.  Learn more about FAST California  here.

Timeline:

• July 1, 2024: Application deadline
• August 2024: Chiesi Discovery Award announced
• September 2024: Program kickoff (virtual)
• December 10, 2024: CLS Innovation Showcase (Bay Area)

Disclosure:

The winner of the Chiesi FAST Discovery Award will be fast-tracked into the Fall FAST 2024 program cohort. A dedicated advisor from Chiesi will participate as an advisor to the selected company and participate in the awardees advisory meetings. 

APPLY HERE»

Please direct any questions or comments to Shikha Sharma at [email protected].

Chiesi Global Rare Diseases is a business unit of the Chiesi Group, a family business striving to create a world where it is common to have a therapy for all diseases and acting as a force for good, for society and the planet.

Global Rare Diseases was founded in February 2020 and based in Boston, established to deliver innovative therapies and solutions for people living with rare diseases and is working to ensure access to treatments, no matter how rare the condition, so as many people as possible can experience their most fulfilling life. The unit collaborates with the rare disease community around the globe to bring voice to underserved people in the health care system. For more information, please visit www.chiesirarediseases.com.